JOHN VASSALLO: Open Payments
NPI 1275590119 · HOWELL, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$953 in 50 payments from 22 companies in 2025. Trend: 2023 $1,355 · 2024 $1,083 · 2025 $953
Food & beverage: $933Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $234 |
| PFIZER INC. | 5 | $90 |
| Novo Nordisk Inc | 5 | $82 |
| Lilly USA, LLC | 3 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| ABBVIE INC. | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: BREZTRI, FARXIGA, ELIQUIS, Rybelsus, CAPLYTA, VRAYLAR, SHINGRIX, Kerendia.
Industry payments across MI — which companies pay providers there.
